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Available online 8 August 2016The OsteoProbe is a second-generation reference point indentation (RPI) devicewithout a reference probe that is
designed to simplify RPI testing for clinical use. Successful clinical implementation of the OsteoProbe would ben-
eﬁt from a better understanding of how its output, bone material strength index (BMSi), relates to the material
properties of bone and under what conditions it reliably correlates with fracture risk. Large animal models have
the potential to help ﬁll this knowledge gap, as cadaveric studies are retrospective and limited by incomplete pa-
tient histories (including the potential use of bone matrix altering drugs such as bisphosphonates). The goal of
this study was to assess the intra and inter-animal variability of OsteoProbe measures in untreated beagle dogs
(n = 12), and to evaluate this variability in comparison to traditional mechanical testing. OsteoProbe measure-
ments were performed in vivo on the left tibia of each dog and repeated 6 months later on the day of sacriﬁce.
Within-animal variation of BMSi (CV of 5–10 indents) averaged 8.9 and 9.0% at the ﬁrst and second timepoints,
respectively. In contrast, inter-animal variation of BMSi increased from 5.3% to 9.1%. The group variation of BMSi
was on par with that of traditional 3-pointmechanical testing; inter-animal variation was 10% for ultimate force,
13% for stiffness, and 12% for totalwork asmeasured on the femur. Therewas no signiﬁcant change inmeanBMSi
after 6months, but the individual changewith time across the 12 dogswas highly variable, ranging from−12.4%
to +21.7% (mean 1.6%, SD 10.6%). No signiﬁcant correlations were found between in vivo tibia BMSi and femur
mechanical properties measured by ex vivo 3-pt bending, but this may be a limitation of sample size or the tests
being performed on different bones. No relationship was found between BMSi and tissue mineral density, but a
strong positive correlation was found between BMSi and tibia cortical thickness (ρ=0.706, p= 0.010). This re-
port shows that while the OsteoProbe device has inter-individual variability quite similar to that of traditional
mechanical testing, the longitudinal changes show high levels of heterogeneity across subjects. We further high-
light the need for standardization in post-testing data processing and further study of the relationships between
OsteoProbe and traditional mechanical testing.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Variability1. Introduction
A signiﬁcant limitation in the quest to reduce fracture risk has been
the inability to predict that risk on an individual basis. Bone mineral
density (BMD) has long been the gold standard for assessing fracture
risk, however the limitations of such imaging are well appreciated
(Kanis, 2002; Sarkar et al., 2002). This limitation of BMD is not surpris-
ing given that the fracture resistance of a bone is multi-factorial – deter-
mined bynot only bonemass (which can be estimated by BMD)but also
its geometry/architecture and its material properties. Advances inell Biology, MS 5035, Indiana
lis, IN 46202, United States.
. This is an open access article underclinical imaging havemademeasures of geometry/architecture possible
while assessing material properties has proven more difﬁcult.
Indentation methods have long been used to assess bone's material
properties (see reviews (Thurner, 2009; Zysset, 2009)). Indentation
methods have recently been adapted into two devices that facilitate in
vivo measurements of local mechanical properties. BioDent, an early
generation device originally proposed for clinical use (Diez-Perez et
al., 2010), utilizes a reference probe-based indentation method which
cyclically indents the bone surface to provide various pieces of data
linked to tissue mechanical properties (e.g. indentation depth,
unloading slope, energy dissipation) (Bridges et al., 2012; Hansma et
al., 2008). This technique has been shown to differentiate fracture/
non-fracture patients (Diez-Perez et al., 2010) yet the majority of data
have been generated from laboratory experiments, either on bone spec-
imens or in vivo using animal models (Beutel and Kennedy, 2015;the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. OsteoProbe in use in vivo.
193E.M.B. McNerny et al. / Bone Reports 5 (2016) 192–198Granke et al., 2014; Gallant et al., 2013; Aref et al., 2013). A newer gen-
eration device, OsteoProbe, designed in part to make clinical use more
straightforward (Bridges et al., 2012), uses similar yet distinct methods
to assess indentation properties. It lacks a reference probe and instead
relies on a pre-load trigger reference point followed by a single high-
force impact fromwhich the depth of penetration into the bone is deter-
mined (Bridges et al., 2012). This device has been used in several clinical
studies andwas able to differentiate bone properties in diabetic/non-di-
abetic patients (Farr et al., 2014; Furst et al., 2016), effects of glucocorti-
coids/treatments (Mellibovsky et al., 2015), fracture/non-fracture
osteopenic patients (Malgo et al., 2015), and Norwegian/Spanish
women (Duarte Sosa et al., 2015), but BMSi did not show an association
with vertebral fractures in a cohort of older women (Rudäng et al.,
2016). While the OsteoProbe has potential to ﬁll a unique niche in our
ability for in vivo assessment of bone, a number of basic, yet fundamen-
tally essential, questions exist about the device such as the variability
and reproducibility of themeasures. The goal of this study was to assess
variation in the OsteoProbe measure, bone material strength index
(BMSi), within (using longitudinal measures over 6months) and across
a group of untreated beagle dogs in order to deﬁne properties of vari-
ability and reproducibility in a relatively homogenous setting of tissue
properties.
2. Methods
2.1. Experiment design
Twelve skeletally mature female beagle dogs (455 ± 59 days) were
used in this study. Due to housing constraints, these animals were di-
vided across two evenly sized cohorts, housed sequentially over two
years. The ﬁrst cohort was older that the second (starting age Cohort
1: 512± 7 days, Cohort 2: 399±10 days, p b 0.01). These untreated an-
imals comprised the vehicle control group for a larger study and re-
ceived daily oral saline for 1 year. Six months into the study, the dogs
were anesthetized via intravenous propofol to allow in vivo indentation
(OsteoProbe, Active Life Scientiﬁc). At 12 months, in vivo indentations
were repeated at the same site within 15min following animal sacriﬁce
(sodium pentobarbital overdose) and prior to tissue dissection. Right
femora and left tibiae were collected, wrapped in saline-soaked gauze,
and frozen at −20 °C until use. Right tibiae were formalin-ﬁxed and
stored in ethanol. All animal procedures were conducted with prior ap-
proval of the IndianaUniversity School ofMedicineAnimal Care andUse
Committee.
2.2. OsteoProbe
OsteoProbe measurements were performed in vivo on the left tibia
of each dog (6 month timepoint) and repeated 6 months later on the
day of sacriﬁce (12 month timepoint). Both tests were done on the
same leg, as the contralateral limb was dedicated to another assay.
The location for testing was identiﬁed as the linear midpoint between
the superomedial margin of the medial tibial condyle and the
distomedial margin of the medial malleolus. This tibia mid-diaphyseal
location has minimal soft tissue covering the bone in both canines and
humans and is the preferred site in clinical tests (Farr et al., 2014;
Furst et al., 2016; Mellibovsky et al., 2015; Malgo et al., 2015; Duarte
Sosa et al., 2015; Rudäng et al., 2016; Guerri-Fernandez et al., 2014).
The skin was shaved, the site was aseptically prepared, and local anes-
thetic (Bupivacaine + Lidocaine) was injected subcutaneously just
proximal to the testing site. The test probe was carefully inserted
through the lifted skin prior to the ﬁrst indentation. The operator
(JMO) used his opposite hand to move the skin with the probe for
each indentation to prevent tension from the stretched skin from inter-
fering with the probe (Fig. 1). The probe was positioned normal to the
bone surface and the device was slowly lowered over 1–2 s to activate
the indentation cycle, which monitors the indentation depth increaseresulting froman impact load of 30N superimposed on a 10N triggering
preload (40 N total force) (Bridges et al., 2012). Each OsteoProbe mea-
surement session consisted of 5 indentations located at least 2 mm
apart along a line parallel to the long axis of the diaphysis and was per-
formedwithout removing the probe from the skin between indents. The
direction of this spacing was switched (moving proximally or distally
from themidpoint) between 6 and 12months to avoid indenting a pre-
viously tested site. In select cases, 1–5 additional measurements were
made based on our assessment that one ormore indentswere question-
able and warranted ﬂagging for further evaluation. Five indents on the
manufacturer-provided poly(methyl methacrylate) block were per-
formed immediately following each bone test to allow calculation of
the BMSi. A new probe tip was used for each animal at each timepoint.
The probe tips are designated for single patient use and were used as
provided by the manufacturer.
Raw, uncorrected indentation results were used to manually calcu-
late BMSi using the published equation (Bridges et al., 2012). The rea-
sons for manual calculations, rather than using the provided
software's values, were twofold. First, because animals were split across
two cohorts, the full dataset was collected at four time-points spanning
2 years. The OsteoProbe instrument was returned to the manufacturer
between time-points, which allowed for calibration and inspection,
but also resulted in an update to the supplied softwaremid-experiment.
This update slightly changed the software-based calculation of BMSi
(details of the manual calculations and software changes are provided
in the Supplement). Though differences in the BMSi values following
the software update were subtle (Supplement Table), we used manual
calculations to ensure consistency across the full dataset. Manual calcu-
lation also allowed us the opportunity for post-testing decisions about
the inclusion of individual indents, particularly PMMA indents used in
the calculation of corrected BMSi. This was essential when an outlying
(later identiﬁed as invalid) PMMA indent was overlooked during test-
ing, resulting in a warning of a high PMMA standard deviation from
the OsteoProbe software and a suggestion to repeat the test. We opted
194 E.M.B. McNerny et al. / Bone Reports 5 (2016) 192–198to manually calculate the corrected BMSi with the invalid indent ex-
cluded rather than exclude the entire measurement and subject the an-
imal to repeated testing.
Ex vivo OsteoProbe indentationswere performed to test the effect of
indentation location on BMSi and examine potential differences in var-
iation ex vivo. Four fresh-frozen dog tibiae, saved from an unrelated ex-
periment, were stripped of soft tissue and indented 15 times. The
indentation sites were arranged in a grid of 3 indents across the ante-
rior-medial circumference by 5 indents along the proximal length of
the bone, ending at the mid-diaphysis. The OsteoProbe was positioned
normal to the bone surface for all indentations, and the resulting BMSi
measurements were averaged by indentation site.
2.3. pQCT
Right tibiae and femora were assessed ex vivo for volumetric bone
density and geometry using a Norland Stratec XCT Research SA+ pQCT
(Stratec Electronics, Birkenfeld, Germany). A single slice at the bone's
midpoint was scanned using a resolution of 0.07 × 0.07 × 0.50 mm. Vol-
umetric density and standard geometry parameters were obtained using
standard scanner softwarewith a segmentation threshold of 690mg/cm3.
2.4. Whole bone mechanical testing
Three-point bending to failure was performed on the right femora
on a servohydraulic testing system (MTS 858 MiniBionix II, MTS Sys-
tems Corporation). Whole bones were placed on a 5 cm support span,
with the anterior surface tested in tension and themid-diaphysis placed
directly below the center loading point. Hydration of the bones was
maintained with saline irrigation. Bones were loaded under displace-
ment control (1 mm/s) until failure. Recorded load and displacement
data were analyzed with a custom Matlab script and converted to esti-
mated stress-strain curves using engineering beam theory and each
bone's cross-sectional geometry determined by pQCT. Yieldwas deﬁned
using the 0.2% strain offset method. Both whole bone (structural) and
estimated tissue level (material) properties were determined. Primary
properties of interest were ultimate force, stiffness, displacement (pre-
yield, post-yield and total), and work (pre-yield, post-yield, and total).
2.5. Statistical analysis
The intra-animal coefﬁcient of variation (CV) of BMSi was calculated
and averaged by cohort (1 or 2) and time point (6 and 12 months). The
inter-animal (group) CVwas calculated formean BMSi, ﬁnal bodyweight,
and ex vivo measures including bone mineral density, cortical geometry,
and mechanical outcomes from whole bone mechanical testing. GroupTable 1
Animal weight and pQCT measures of bone size and density.
Dog weight
(kg)
Femur length
(mm)
Tibia TMD
(mg/cm3)
Fem
(mg
Overall (n = 12)
Mean 9.1 100.3 1294.5 133
SD 0.8 5.1 23.8 8.3
CV (%) 9.0 5.1 1.8 0.6
Cohort 1 (n = 6)
Mean 9.3 101.2 1306.6 134
SD 0.9 5.4 21.2 6.2
CV (%) 9.7 5.3 1.6 0.5
Cohort 2 (n = 6)
Mean 8.9 99.4 1282.4 133
SD 0.7 5.2 21.1 8.4
CV (%) 8.4 5.2 1.6 0.6
Cohort comparison
(p-values)
Student's 2-tailed t-test 0.402 0.568 0.077 0.07CVs were examined within each cohort (all measures) and time-point
(BMSi only). Change in BMSi between 6 and 12 months was tested
with a paired t-test. The relationships between 12month BMSi andmea-
sures from pQCT and traditional mechanical testing were tested by
Spearman's nonparametric correlation analysis. This nonparametric test
was chosen over Pearson's correlation to allow for the possibility of non-
linear relationships.
3. Results
Endpoint bodyweight and morphological characteristics of the tibia
and femur showedno signiﬁcant differences between cohorts (Table 1).
Overall inter-dog CVs for pQCT measures ranged from 0.6% for femur
tissue mineral density (TMD) to 14.4% for tibia cortical thickness (Ct.
Th). Tibia measures were consistently more variable than correspond-
ing measures on the femur.
The individual indentation results, plotted by animal and time-point,
are presented in Fig. 2. Analysis of the indentation curves for the full
dataset revealed that 4 indents were the result of abnormal tests
based on the shape of the curve having distinct deviation from the typ-
ical curve (Fig. 3). These indentations were excluded from further anal-
ysis. Subsequent to the removal of these values, Dixon Q tests
(Rorabacher, 1991; Dixon, 1950) were used to test for outlier measure-
ments within dog and time point. One indent met the Q test criteria
with N95% conﬁdence and was discarded from further analysis.
The BMSi intra-animal CV was 8.9 and 9.0% for the ﬁrst and second
time-points, respectively, and ranged from 7.8 to 10.0% when consid-
ered separately for each cohort (Table 2). Intra-animal CV was not sig-
niﬁcantly different as a function of timepoint or cohort (Repeated
measures 2-factor ANOVA; Timepoint p = 0.958, Cohort p = 0.724, In-
teraction p= 0.512). Inter-animal variation of BMSi ranged from 5.1 to
9.8% across cohort and time (Table 3) with greater variation observed at
the second time-point.
One animal (animal #2 in Fig. 2) at the 12 month timepoint was re-
measured immediately following the ﬁrst test due to machine
prompting (suggesting the measurements were unstable). The second
set of indents was not used for the primary analysis, but it serves as an
example of measure repeatability (Fig. 4). In this case, immediate
retesting of the same bone resulted in a BMSi of 76.8 (compared to
the initial 69.7).
Percent changes from the ﬁrst to the second BMSi measurement
(6 months apart) were calculated to evaluate the variability of BMSi
measures in these untreated animals over time. As a group, there was
no signiﬁcant change in mean BMSi (Table 4, paired t-test, p = 0.85),
but the individual change with time across the 12 dogs was highly var-
iable, ranging from−12.4% to +21.7% (mean 1.6%, SD 10.6%) (Fig. 5).ur TMD
/cm3)
Tibia Ct.Area
(mm2)
Femur Ct.Area
(mm2)
Tibia Ct.Th
(mm)
Femur Ct.Th
(mm)
9.0 48.4 45.0 2.5 1.9
6.5 3.7 0.4 0.2
13.5 8.2 14.4 9.6
3.3 46.5 45.2 2.5 1.9
7.0 4.0 0.4 0.2
15.1 8.8 18.0 12.8
4.8 50.3 44.9 2.6 1.9
6.0 3.8 0.3 0.1
11.9 8.4 10.9 6.4
1 0.337 0.891 0.435 0.775
Timepoint
6 months
12 months
Included
Excluded (atypical curve)
Excluded (Dixon Q outlier)
Data Processing
Fig. 2. Individual BMSi values of indentations performed for each animal at 6 and
12 months. Shaded data points were excluded from further analysis due to abnormal
indentation curve shape (black) or outlier identiﬁcation by Dixon Q testing (gray).
Table 2
BMSi intra-animal coefﬁcient of variation. Presented as mean (SD).
Cohort 1 (n = 6) Cohort 2 (n = 6) All animals (n = 12)
6 months 10.0 (5.1) 7.8 (5.9) 8.9 (5.4)
12 months 8.8 (5.7) 9.2 (3.4) 9.0 (4.5)
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in BMSi on the anterior-medial surface both proximally to distally and
anteriorly to medially (Fig. 6). The instrument failed to register the
test at the 15th indent site (Fig. 6) on all bones tested and the 14th in-
dent site on 2 bones. The variability within each bone averaged
10.2% ± 1.3. Averaging the indents for each bone to a single value, the
4 bones had an average BMSi of 72.3 ± 3.7 (5.1% CV).
Traditional 3-point mechanical testing on the femur determined
whole bone mechanical properties including ultimate strength, stiff-
ness, and work to failure (Table 5). There were nomean differences be-
tween the cohorts for any mechanical properties. Overall, inter-animal
CV was 10% for ultimate force, 13% for stiffness, and 12% for total
work. The greatest variability was observed for post-yield measures,
with post-yield displacement and post-yield work both having a CV of
17%.
No signiﬁcant correlations (Table 6) were found between in vivo
tibia BMSi at 12 months and femur mechanical properties measured
by ex vivo 3-pt bending. However, the trends suggest positive relation-
ships between BMSi and measures of stiffness and ultimate strength
and negative relationships between BMSi andmeasures of deformation
(displacement) and energy absorption (work). These trends were mir-
rored for measures of tissue-level strength (stress) and energy absorp-
tion (toughness) normalized for bone size, but these relationships
were also not statistically signiﬁcant in this small sample. No signiﬁcant
relationship was found between BMSi and tissue mineral density, but a
strong positive correlation was found between BMSi and tibia cortical
thickness (ρ= 0.706, p = 0.010).1
6
5
4
3
2
Fig. 3. The plotted indentation data from animal #8 at 12 months shows an example of an
atypical test curve (line 6), clearly different from the test curve shape usually observed for
bone (lines 1–5). Indentationswith abnormal curveswere excluded from analysis (Fig. 2).4. Discussion
The study of bone mechanical properties has, until recently, been
limited to ex vivo measurements. The reference point indentation
(RPI) devices, BioDent and OsteoProbe, were developed to provide an
in vivo mechanical assessment of bone tissue properties (Bridges et
al., 2012; Hansma et al., 2008). Although BioDent was originally used
in patients, this device has been supplanted by the OsteoProbe which
has been used in several recent clinical studies (Farr et al., 2014; Furst
et al., 2016; Mellibovsky et al., 2015; Malgo et al., 2015; Duarte Sosa et
al., 2015; Rudäng et al., 2016). As outlined in a recent review (Allen et
al., 2015), although the OsteoProbe may hold promise as a clinical
tool, this instrument outputs a novel parameter, BMSi, which requires
additional study to help in the interpretation of its meaning. The goal
of this study was to contribute to this understanding by assessing the
variability of the OsteoProbe machine in a cohort of untreated dogs.
We also aimed to examine relationships between BMSi and bone geom-
etry andmechanical properties. The relationship between BMSi and ap-
parent mechanical properties is complicated by bone's heterogeneity,
anisotropy, and viscoelasticity, which can be expected to affect the
OsteoProbe and whole bone bending tests differently, but the presence
of a correlation would be helpful to understanding and interpreting the
relatively new BMSi metric.
Based on the manufacturers recommendation and provided soft-
ware, multiple OsteoProbe indentations are performed and averaged
into a single BMSi measurement for a given patient or sample.
(Bridges et al., 2012) This is good practice given a bone's heterogeneity
and the multiple sources of error possible for any single indentation (e.
g. soft tissue interference, angle between the probe and bone surface,
probe slippage). The in vivo intra-measure CV of 9% for BMSi in the
dogs is on parwith the variability reported in two in vivo human studies
(9–10%) (Malgo et al., 2015; Duarte Sosa et al., 2015), although a third
reports achieving a precision of 1.65%. (Farr et al., 2014) Our ex vivo
tests performed on dog tibiae demonstrated signiﬁcant patterns of spa-
tial variability for BMSi (Fig. 6), with greater differences around the cir-
cumference of the bone than down its length. This ﬁnding guided our
decision to collect in vivo indents in a single line, roughly parallel to
the long axis. Despite our best efforts, high spatial variability is a plausi-
ble explanation for the 10% change in BMSi found when one measure
was immediately repeated (Fig. 4). In the ex vivo tests, the range of
BMSi measured for each of the four tibia covered a range of about 20
(~60–80), clustered by location. An early review of the OsteoProbe
(Randall et al., 2013) contrasted the difference in variability between a
human in vivo test and the plastic standard to demonstrate the effects
of bone heterogeneity on BMSi. In this human test using 7 indents, the
BMSi ranged from ~80–100, indicating the spread observed in the dog
tibia is not unique to the dog model or test operator. It would be rele-
vant to explore whether alterations in bone heterogeneity, often associ-
atedwith aging andbonedisease (Bala and Seeman, 2015), are reﬂected
in OsteoProbe measurement variability and affect test repeatability and
statistical power. Alternatively, assessment of BMSi intra-measureTable 3
BMSi inter-animal coefﬁcient of variation.
Cohort 1 (n = 6) Cohort 2 (n = 6) All animals (n = 12)
6 months 5.1 5.3 5.3
12 months 9.0 9.8 9.1
First Test Repeat Test
Fig. 4. Individual BMSi values of indentations from initial and repeated OsteoProbe
measurements performed on animal #2 at 12 months. Retesting resulted in a mean
BMSi of 76.8 compared to the initial mean BMSi of 69.7 (p = 0.065, paired t-test).
Fig. 5. Percent change in BMSi between 6 and 12 months is presented for each animal
(single value) and for the average of all animals (mean ± standard deviation).
196 E.M.B. McNerny et al. / Bone Reports 5 (2016) 192–198variation could potentially prove to be a useful way to assess bone
heterogeneity.
Overall, the clinical studies report mean in vivo BMSi values ranging
from approximately 65 to 85, inclusive of individualswith known fragil-
ity fractures, (Farr et al., 2014; Furst et al., 2016;Mellibovsky et al., 2015;
Malgo et al., 2015; Duarte Sosa et al., 2015; Rudäng et al., 2016;
Guerri-Fernandez et al., 2014). The BMSi in these healthy, untreated
dogs averaged 69. Our whole bone mechanical test results (Table 3),
as well as the health and age of the dogs, do not support the presence
of fragility in these animals. This highlights the fact that differences in
BMSi between populations or individuals may reﬂect factors other
than compromised bone quality; any characteristic that allows greater
probe penetration, such as lower mineralization or osteoid at the bone
periosteal surface, could contribute to a reduced BMSi. In order for the
OsteoProbe to reach its maximum utility in research or clinical use, ad-
ditional studies are needed that explore the properties of bone contrib-
uting to the BMSi measurement and how their inﬂuences differ across
species, age and disease. In other words, the relationship between a
given BMSi value and bone fragility almost certainly differs across pa-
tient populations. Even across comparable populations, very different
absolute BMSi values have been reported; two studies examining pa-
tients with Type II diabetes in post-menopausal women reported
mean diabetic BMSi values of 63.7 (Furst et al., 2016) and 77.2 (Farr et
al., 2014), though both reports found reductions in BMSi on the order
of 10% compared to their respective matched controls.
One main goal of this study was to assess the longitudinal measure-
ment potential of the OsteoProbe. As opposed to human data, where
changes in material properties are most certainly occurring over time
in treated or control patients, these untreated dogs likely have modest
changes over the 6-month period. The mean BMSi did not signiﬁcantly
change between 6 and 12 months, but the individual animal response
was quite variable. Also, the inter-animal CV increased with time,
from 5 to 9%, an observation consistent for both cohorts. It is possible
these patterns are a result of the tests being repeated on the same
bone at the same location, although our approach was designed to pre-
vent direct overlap of indentations. Damage induced by the ﬁrst round
of testing could conceivably affect the second test either directly, if the
damage was not fully repaired in the intervening 6 months, orTable 4
Average BMSi by cohort and timepoint. Presented as mean (SD).
Cohort 1 (n = 6) Cohort 2 (n = 6) All animals (n = 12)
6 months 70.3 (3.6) 67.9 (3.6) 69.1 (3.6)
12 months 70.4 (6.4) 68.6 (6.7) 69.5 (6.3)indirectly, if the ﬁrst round induced an inﬂammatory or turnover re-
sponse at the testing site. Future work should explore the damage in-
duced by in vivo testing, how this heals over time, and what effect this
has on BMSi measures.
To help place the variability of OsteoProbe in context, we compared
the 12-month inter-animal variability of the OsteoProbe with that of
traditional mechanical properties (Table 3) andmorphological parame-
ters including bodyweight, bone density, and bone size (Table 4). Nota-
bly, the OsteoProbe's inter-animal variability was less than that of
ultimate force, the parameter commonly used when performing
power analyses for experiments testing bonemechanics. This is promis-
ing for the adoption of OsteoProbe in experiments already powered to
detect differences inmechanical properties using traditional ex vivo ap-
proaches, assuming BMSi mean differences are of a comparable size.
Although variability of the OsteoProbewas on par with that of tradi-
tional mechanical testing, there were no signiﬁcant correlations be-
tween tibia BMSi and femur mechanical properties. This may be due
to the relatively small group size or the tests being performed on differ-
ent bones. Despite this, a signiﬁcant positive correlation was observed
between cortical thickness and BMSi. This could potentially be ex-
plained by overall deﬂection or ring deformation of the cortex, resulting
in an artifactual increase in themeasured indentation increase from im-
pact during OsteoProbe testing. Additional study is needed to under-
stand the limits and behavior of the OsteoProbe with respect to bone
size. Since the device was originally designed for clinical use, with
human tibia cortical thickness on the order of 4–10 mm at the mid-di-
aphysis (Capozza et al., 2010), it is possible that the force of the impact
is larger than is ideal for use in canines and similarly sized animals.
One aspect of the OsteoProbe device that became an important issue
to consider during our studywas the handling of irregular/bad tests. The
goal of the multiple-indent test session is to achieve a fair representa-
tion of the overall bone properties with the ﬁnal BMSi. However, as
with any small sample size, extremevalues have disproportionate inﬂu-
ence on the mean, whether they stem from measurement error or nat-
ural variation. The OsteoProbe software gives the user the ability to ﬂag
measurements and thereby remove them from the calculated BMSi. Un-
fortunately, there is no guidance in the literature for how to standardize
this practice. Our laboratory chose to plot indentation distance vs time
for each curve during our post-testing analysis. In some cases, we
found that outlying values could be identiﬁed as invalid measurements
by the shape of the indentation curves (Fig. 3). Although these points
appeared to be possible outlierswhen viewed in the context of the sam-
ple in which they appeared, the invalid indentations resulted in BMSi
values within the range of values from other animals in the experiment
Location
M
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n 
B
M
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A B
3 2 1
6 5 4
9 8 7
12 11 10
15* 14 13
Location
2.5 cm
Fig. 6. (A) Ex vivo indentations were performed on dog tibiae (n= 4) at 15 locations in a grid on the anterior-medial surface. (B) BMSi (mean± st dev) is plotted as a function of indent
location. Patterns of spatial variabilitywere observed along both the length and around the circumference of the bone. *Indentationsﬁred but failed to register at site 15 for all bones tested.
197E.M.B. McNerny et al. / Bone Reports 5 (2016) 192–198(Fig. 2).We propose that until clear guidelines are developed for includ-
ing/excluding data, users should plot and examine the curves for all in-
dentations, and not just suspected outliers, as a ﬁrst screen of data
quality. In our hands, even after this curve-by-curve inspection, other
outlying indentations with valid test curves and no user observations
(e.g. the probe slipped) to indicate testing error existed. We used the
Dixon Q statistic to objectively identify which of these values were dis-
cardable outliers with 95% conﬁdence. The Dixon Q is speciﬁcally de-
signed for small sample sizes and is commonly used to detect outliers
in replicate measurements. Development of standardized ways to eval-
uate individual indents will help to assure uniformity in data handling
across laboratories and within groups between studies.
There are several limitations to our study. Although some of our var-
iation data are comparable to those published on humans, whether or
not the high heterogeneity in change over time in these dogs is more/
less than humans remains unknown. It is possible that the higher
bone mass of an adult human bone, compared to these dogs, might
alter the reproducibility. Our correlation to traditionalmechanical prop-
erties necessitates using different bones (tibia vs femur) and thus it's
possible that stronger relationships would exist if the same bone were
used for both measures. Whole bone mechanical tests were performedTable 5
Whole bone mechanical properties of the femur at 12 months (n = 12).
Ultimate force
(N)
Displacement to
yield
(μm)
Postyield displacement
(μm)
Tota
(μm
Overall
Mean 1438 1036 1848 2885
SD 145 89 322 331
CV (%) 10 9 17 11
Cohort 1
Mean 1448 1050 1892 2942
SD 210 124 435 442
CV (%) 15 12 23 15
Cohort 2
Mean 1428 1023 1805 2828
SD 53 47 200 206
CV (%) 4 5 11 7
Cohort comparison (p-values)
Student's 2-tailed
t-test
0.847 0.658 0.699 0.61on the femur to avoid the possible inﬂuence of damage from the inden-
tation tests on the results. While we chose to perform whole bone tests
to focus on the correlation of BMSi with apparent level mechanical
properties, another approach would be to machine beams of controlled
size to more speciﬁcally measure tissue level mechanical properties
closer to the site of OsteoProbe testing.Mechanical propertiesmeasured
on these beams might better correlate with BMSi than our whole bone
tests, but it would be important to avoid inclusion of the actual indenta-
tion sites within the testing span of the beam. It is also possible that
stronger correlations would exist to other more clinically relevant skel-
etal sites, such as the femoral neck or vertebra. Finally, although the fact
that we used healthy dogs was an advantage for answering the ques-
tions about reproducibility, it is possible that detecting changes over
time would have less variability in situations where bone deterioration
is occurring.
In conclusion, this report shows that while the OsteoProbe device
has inter-individual variability quite similar to that of traditional
mechanical testing, the longitudinal measures show high levels of het-
erogeneity across subjects. We further highlight the need for standard-
ization in post-testing data processing to help assure similarities across
centers using this device.l displacement
)
Stiffness
(N/mm)
Work to yield
(mJ)
Postyield work
(mJ)
Total work
(mJ)
1268 642 2517 3159
159 64 418 390
13 10 17 12
1249 647 2567 3214
229 87 556 506
18 14 22 16
1286 638 2467 3105
56 39 279 282
4 6 11 9
4 0.744 0.838 0.733 0.689
Table 6
Correlation with 12-month BMSi.
Spearman's rho p value
Femur 3-point bending measures
Ultimate force 0.248 0.489
Displacement to yield −0.358 0.310
Post-yield displacement −0.455 0.187
Total displacement −0.430 0.214
Stiffness 0.358 0.310
Work to yield 0.079 0.829
Post-yield work −0.236 0.511
Total work −0.285 0.425
Femur 3-pt estimated tissue level properties
Ultimate stress 0.442 0.200
Modulus 0.515 0.128
Strain to yield −0.564 0.090
Resilience 0.018 0.960
Toughness −0.176 0.627
Tibia pQCT
TMD −0.490 0.106
Ct.Area 0.566 0.055
Ct.Th 0.706 0.010
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